Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Pasritamig combination delivers 73% PSA response rate in advanced prostate cancer Phase I study


FDA grants Priority Review to BRUKINSA combination in first-line mantle cell lymphoma


Regeneron CIDEBsiRNA delivers up to 80% liver fat reduction in early MASLD study


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Assessing the Risk of Interaction Between Extractables and Leachable and Therapeutic Proteins

Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca & Piet Christieans, PhD, Scientific Director at Nelson Lab
14th May 2020


Overcoming Downstream Bottlenecks In The Upscaling Process

Presented by Dr. Dakshesh Mehta, Associate Vice President and Head of Bioprocess Group at Biotech & Genomics division, Wockhardt Research Center
17th January 2019


Analytical Challenges for Gene Therapy

Presented by Clare Blue, Director of Analytical Development at Biogen and Saba Hussein, Applications Manager and Senior Scientist at Vironova
03rd November 2020


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia